Conservation of aging and cancer epigenetic signatures across human and mouse

Aging and cancer are two interrelated processes, with aging being a major risk factor for the development of cancer. Parallel epigenetic alterations have been described for both, although differences, especially within the DNA hypomethylation scenario, have also been recently reported. Although many...

Descripción completa

Detalles Bibliográficos
Autores: Pérez, Raúl F., Tejedor, Juan Ramón, Santamarina-Ojeda, Pablo, López, Virginia, Urdinguio, Rocío G., Villamañán, Lucía, Candiota, Ana Paula, Vidal Sarró, Noemí, Barradas, Marta, Fernández-Marcos, Pablo José, Serrano, Manuel, Fernández, Agustín F., Fraga, Mario F.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/259063
Acceso en línea:http://hdl.handle.net/10261/259063
Access Level:acceso abierto
Palabra clave:Epigenetics
Conservation
DNA methylation
Human
Histone modification
Mouse
id ES_bf9d0e06ed948b82bfbeff102ee5a478
oai_identifier_str oai:digital.csic.es:10261/259063
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv Conservation of aging and cancer epigenetic signatures across human and mouse
title Conservation of aging and cancer epigenetic signatures across human and mouse
spellingShingle Conservation of aging and cancer epigenetic signatures across human and mouse
Pérez, Raúl F.
Epigenetics
Conservation
DNA methylation
Human
Histone modification
Mouse
title_short Conservation of aging and cancer epigenetic signatures across human and mouse
title_full Conservation of aging and cancer epigenetic signatures across human and mouse
title_fullStr Conservation of aging and cancer epigenetic signatures across human and mouse
title_full_unstemmed Conservation of aging and cancer epigenetic signatures across human and mouse
title_sort Conservation of aging and cancer epigenetic signatures across human and mouse
dc.creator.none.fl_str_mv Pérez, Raúl F.
Tejedor, Juan Ramón
Santamarina-Ojeda, Pablo
López, Virginia
Urdinguio, Rocío G.
Villamañán, Lucía
Candiota, Ana Paula
Vidal Sarró, Noemí
Barradas, Marta
Fernández-Marcos, Pablo José
Serrano, Manuel
Fernández, Agustín F.
Fraga, Mario F.
author Pérez, Raúl F.
author_facet Pérez, Raúl F.
Tejedor, Juan Ramón
Santamarina-Ojeda, Pablo
López, Virginia
Urdinguio, Rocío G.
Villamañán, Lucía
Candiota, Ana Paula
Vidal Sarró, Noemí
Barradas, Marta
Fernández-Marcos, Pablo José
Serrano, Manuel
Fernández, Agustín F.
Fraga, Mario F.
author_role author
author2 Tejedor, Juan Ramón
Santamarina-Ojeda, Pablo
López, Virginia
Urdinguio, Rocío G.
Villamañán, Lucía
Candiota, Ana Paula
Vidal Sarró, Noemí
Barradas, Marta
Fernández-Marcos, Pablo José
Serrano, Manuel
Fernández, Agustín F.
Fraga, Mario F.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Asociación Española Contra el Cáncer
Fundación General CSIC
European Commission
Instituto de Salud Carlos III
Principado de Asturias
European Commission
Fundación Ramón Areces
Agencia Estatal de Investigación (España)
Ministerio de Ciencia, Innovación y Universidades (España)
Universidad Autónoma de Barcelona
Ministerio de Economía y Competitividad (España)
Obra Social Cajastur
Liberbank
Instituto Madrileño de Investigación y Desarrollo Rural, Agrario y Alimentario
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv Epigenetics
Conservation
DNA methylation
Human
Histone modification
Mouse
topic Epigenetics
Conservation
DNA methylation
Human
Histone modification
Mouse
description Aging and cancer are two interrelated processes, with aging being a major risk factor for the development of cancer. Parallel epigenetic alterations have been described for both, although differences, especially within the DNA hypomethylation scenario, have also been recently reported. Although many of these observations arise from the use of mouse models, there is a lack of systematic comparisons of human and mouse epigenetic patterns in the context of disease. However, such comparisons are significant as they allow to establish the extent to which some of the observed similarities or differences arise from pre-existing species-specific epigenetic traits. Here, we have used reduced representation bisulfite sequencing to profile the brain methylomes of young and old, tumoral and nontumoral brain samples from human and mouse. We first characterized the baseline epigenomic patterns of the species and subsequently focused on the DNA methylation alterations associated with cancer and aging. Next, we described the functional genomic and epigenomic context associated with the alterations, and finally, we integrated our data to study interspecies DNA methylation levels at orthologous CpG sites. Globally, we found considerable differences between the characteristics of DNA methylation alterations in cancer and aging in both species. Moreover, we describe robust evidence for the conservation of the specific cancer and aging epigenomic signatures in human and mouse. Our observations point toward the preservation of the functional consequences of these alterations at multiple levels of genomic regulation. Finally, our analyses reveal a role for the genomic context in explaining disease- and species-specific epigenetic traits.
publishDate 2021
dc.date.none.fl_str_mv 2021
2022
2022
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_6501
Publisher's version
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/259063
url http://hdl.handle.net/10261/259063
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv #PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-85766-R
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC-2017-22335
info:eu-repo/grantAgreement/EC/H2020/777222
info:eu-repo/grantAgreement/MINECO//FJCI-2015-26965
https://doi.org/10.1093/molbev/msab112

dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418406977994753
spelling Conservation of aging and cancer epigenetic signatures across human and mousePérez, Raúl F.Tejedor, Juan RamónSantamarina-Ojeda, PabloLópez, VirginiaUrdinguio, Rocío G.Villamañán, LucíaCandiota, Ana PaulaVidal Sarró, NoemíBarradas, MartaFernández-Marcos, Pablo JoséSerrano, ManuelFernández, Agustín F.Fraga, Mario F.EpigeneticsConservationDNA methylationHumanHistone modificationMouseAging and cancer are two interrelated processes, with aging being a major risk factor for the development of cancer. Parallel epigenetic alterations have been described for both, although differences, especially within the DNA hypomethylation scenario, have also been recently reported. Although many of these observations arise from the use of mouse models, there is a lack of systematic comparisons of human and mouse epigenetic patterns in the context of disease. However, such comparisons are significant as they allow to establish the extent to which some of the observed similarities or differences arise from pre-existing species-specific epigenetic traits. Here, we have used reduced representation bisulfite sequencing to profile the brain methylomes of young and old, tumoral and nontumoral brain samples from human and mouse. We first characterized the baseline epigenomic patterns of the species and subsequently focused on the DNA methylation alterations associated with cancer and aging. Next, we described the functional genomic and epigenomic context associated with the alterations, and finally, we integrated our data to study interspecies DNA methylation levels at orthologous CpG sites. Globally, we found considerable differences between the characteristics of DNA methylation alterations in cancer and aging in both species. Moreover, we describe robust evidence for the conservation of the specific cancer and aging epigenomic signatures in human and mouse. Our observations point toward the preservation of the functional consequences of these alterations at multiple levels of genomic regulation. Finally, our analyses reveal a role for the genomic context in explaining disease- and species-specific epigenetic traits.This work was supported by the Spanish Association Against Cancer (PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) cofunding 2018-2022/FEDER (IDI/2018/146 to M.F.F.), Fundación General CSIC (0348_CIE_6_E to M.F.F.), and the Health Institute Carlos III (Plan Nacional de I + D+I) cofunding FEDER (PI15/00892 and PI18/01527 to M.F.F and A.F.F.). They also acknowledge support from the Ramón Areces Foundation (CIVP18A3891 to P.J.F.M.), the AECC (SIRTBIO to P.J.F.M.), the MICINN (SAF2017-85766-R to P.J.F.M.), a Ramón y Cajal fellowship (MICINN, RYC-2017-22335 to P.J.F.M.), and the European Commission ATTRACT project (777222 to A.P.C.). J.R.T. is supported by a Juan de la Cierva fellowship from the Spanish Ministry of Science and Innovation (FJCI-2015-26965). R.F.P. and P.S.O. are supported by the Severo Ochoa program (BP17-114 and BP17-165, respectively). R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (Health Institute Carlos III). L.V. was supported by the UAB Predoctoral training programme (PIF predoctoral fellowships). They also acknowledge support from the IMDEA Food Institute and IUOPA-ISPA-FINBA (the IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain).Peer reviewedOxford University PressAsociación Española Contra el CáncerFundación General CSICEuropean CommissionInstituto de Salud Carlos IIIPrincipado de AsturiasEuropean CommissionFundación Ramón ArecesAgencia Estatal de Investigación (España)Ministerio de Ciencia, Innovación y Universidades (España)Universidad Autónoma de BarcelonaMinisterio de Economía y Competitividad (España)Obra Social CajasturLiberbankInstituto Madrileño de Investigación y Desarrollo Rural, Agrario y AlimentarioConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]202220222021info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/259063reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglés#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-85766-Rinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RYC-2017-22335info:eu-repo/grantAgreement/EC/H2020/777222info:eu-repo/grantAgreement/MINECO//FJCI-2015-26965https://doi.org/10.1093/molbev/msab112Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2590632026-05-22T06:33:51Z
score 15.811543